Alexander M. Gold
Director/Board Member at MINERALYS THERAPEUTICS, INC.
Net worth: - $ as of 31/05/2024
Alexander M. Gold active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Director/Board Member | 13/06/2024 | - |
| Independent Dir/Board Member | 13/06/2024 | - |
Career history of Alexander M. Gold
Former positions of Alexander M. Gold
| Companies | Position | Start | End |
|---|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2013 | 01/10/2017 |
| REATA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2012 | - |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Director/Board Member | 01/01/2001 | - |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Chief Tech/Sci/R&D Officer | - | - |
| President | - | - |
Training of Alexander M. Gold
| Brandeis University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Statistics
International
| United States | 7 |
| Spain | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Health Technology |
- Stock Market
- Insiders
- Alexander M. Gold
- Experience
